$SPRB · 海外大V持仓追踪

$SPRB 现在是什么情况？

最近有人说了 $SPRB 什么？

下面是最近 5 条提及 $SPRB 的公开帖，按时间倒序。每条都附原帖链接，可自行核对。

• 2025-10-06看多原文
  I was looking at $SPRB after @MartinShkreli posted about it and it’s TA-ERT, breakthrough enzyme therapy replacement. Just from a quick search if SPRB’s TA-ERT is approved and they capture 10-15% market share longer term ($180–$270M ARR) of $1.4B US market... Realistic fair value today could be ~$280m-630m MC from 2-3x rev calculations. Obviously there’s a lot of risk from clinical failures, commercialization, to dilution but a $85M market cap looks promising? (disclosure I bought $50k worth just as a high risk gamble) Obviously I’m not an expert in biotech and this is outside my domain, which is why I wanted to see if anyone else with any domain knowledge had feedback or red flags.
  查看原帖 →
• 2025-10-06中性原文
  @tr90605549 Oh I’m just trying to crowdsource information on $SPRB to learn more, not share a directional opinion. I genuinely have zero clue about biotech.
  查看原帖 →
• 2025-10-06中性原文
  TLDR: Might go up to $500 temporary strike if there's no dilution just because of TA-ERT catalyst. But it's playing Russian Roulette on dilution days. So had some more time to look into things: Fair value $SPRB market cap is = ~$150–200m. ($85M now). In OP's post they claimed $500 PT, which is fair if company doesn't dilute. However: SPRB has $16.4M in cash equivalents, June 30, 2025, dilution with new shares seems inevitable just because of low cahs balance. Price rise was due to low float + good news (there's no short interest like .16% so not a short squeeze) After issuing new shares + dilution (Market cap at $150m-$200m might normalize share price to ~$50-75), don't really see the $500 figure if dilution is included. We might see another 100%+ runup just because of limited float toward that $500 mark (like how $BULL ran to a $60B MC off low float), but I would be against holding it long term because of russian roulette dilution on a random day. Either way, I like playing Russian Roulette. Welcome any counterpoints
  查看原帖 →
• 2025-10-06中性原文
  Monday October 6th Market Close Thoughts: - $NBIS extremely good dip buy. Down 2.38% after rising 5.78% in the morning. All other Neoclouds from $IREN to $CIFR held their 4%-14%+ gains. Nebius likely influenced by option flow, should play catchup soon and I stand by $225 PT. - $AMZN, $META two Mag7 that should outperform next 2-3 months and play catchup with the rest. Especially Amazon. - $SNAP, $RDDT two good recovery plays. Snapchat especially because of the revenue monetization changes. If you have the patience for shares for a year or two, I'd expect a 50%+ return, just whenever the market wants to price it in. Not everyone has patience and opportunity cost using the funds in $SNAP instead of Neoclouds might not be worth. Reddit I've maintained that the citations from ChatGPT is a BS reason for a 29% sell-off so I bought into it. - $SPRB caught everyone's attention. I do expect it to keep rising to a $150-$200m marketcap from $75m but it's like playing Russian Roulette, usually dilution happens 2-3 days after a major event. - Stuff like $RKLB, just need to hold lol. It's genuinely overvalued even if it's highest conviction 5Y long but at this point it might pull a $PLTR. - $AMD x OpenAI deal heavily bullish for semi industry. I expected $TSM, $ASML, energy stocks and Neoclouds to get a boost from AI infra buildout. Main negative ones were $CRWV, because of $NVDA dependencies and obviously NVDA, but Neoclouds aren't locked into one player, and they already have 5-10+ year contracts locked in. It just puts a tiny dent in the $NVDA moat idea but nothing material yet. I personally think AMD might pull an $ORCL where it dips past rally, and then ends up pulling an $AVGO when markets start pricing in forward revenue. Then again, I don't know where OpenAI is getting all this money to promise Oracle, AMD, etc. all these ten or hundred billion dollar deals if they're valued at 500B lol. - Gold rallying to ATH every day just signals that $BTC is always a good buy, even at $123k, if it ends up becoming a hedge against inflation. It's close to 1/10th the market-cap. - $LTC still a great buy because of ETF approval. There's the government shutdown so people just forgot it hasn't happened yet, but should get approved eventually. - $VIRT great buy at $32.5, I'd cost average around this range (sorry if you bought calls at $36, my positions are down 35% or so). But again it's an asymmetrical hedge to VIX (VIX IV very high for hedging, VIRT is undervalued ~6.3 forward p/e with buybacks an low IV), so even if positions are down, your other stocks should go up to balance it out. - Still looking into other beneficiaries of buildouts from energy stocks, small caps like $EOSE, memory like $MU, etc. that followers recommended. I try not to talk about something much until I'm informed myself. - If you're on leverage or going long, now is the time to do it until January. 3x rate cut, market probably frontrunning Oct rate cut now.
  查看原帖 →
• 2025-10-06看空原文
  I have no words… +$37K on $SPRB in 2 hours ($21K realized). Ended up taking profit on most. It’s not much to me but I just find this amusing given the short timeframe and had nobody to share it with. I’ll hold $30k worth to see where it goes. https://t.co/ywK3ozncPA
  查看原帖 →

去哪看 $SPRB 的完整时间线？

全部提及推文的中文时间线、每日推演、博主多空表态筛选，在 Serenity 持仓雷达里查看。相关工具：卡点猎手研究方法 · 策略回测器 · 催化剂雷达 · 深度长文。

常见问题

同板块还有哪些个股在被讨论？

$ORCL · $EWY · $ALAB · $VLN · $CRDO · $LPTH · $XLU · $PLTR · $NBIS · $SIVE · $LITE · $AXTI　·　查看全部个股索引 →